The Alphabet, GSK, WuXi AppTec, Johnson & Johnson, Roche and Illumina-backed genetic testing service has now raised over $870m altogether.
US-headquartered genetic testing kit provider 23andme, which counts corporates Alphabet, WuXi AppTec, Johnson & Johnson, GlaxoSmithKline (GSK), Roche and Illumina as investors, has secured $82.5m in funding, according to a regulatory filing.
The funding represents a series F round co-led by venture capital firms Sequoia Capital and NewView Capital, company spokesperson Andy Kill told the Wall Street Journal.
Customers take samples of their DNA using 23andme’s kits and send them back in order to get results about their ancestry and…
